Global Bronchiectasis Therapeutic Market Growth (Status and Outlook) 2025-2031

September 2025 | 90 pages | ID: GABAE5343373EN
LP Information

Abstracts

According to this study, the global Bronchiectasis Therapeutic market size will reach US$ million by 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Bronchiectasis Therapeutic Industry Forecast” looks at past sales and reviews total world Bronchiectasis Therapeutic sales in 2024, providing a comprehensive analysis by region and market sector of projected Bronchiectasis Therapeutic sales for 2025 through 2031. With Bronchiectasis Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bronchiectasis Therapeutic industry.

This Insight Report provides a comprehensive analysis of the global Bronchiectasis Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bronchiectasis Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bronchiectasis Therapeutic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bronchiectasis Therapeutic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bronchiectasis Therapeutic.

This report presents a comprehensive overview, market shares, and growth opportunities of Bronchiectasis Therapeutic market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Antibiotics
• Expectorants
• Others

Segmentation by Application:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GlaxoSmithKline
• Alitair Pharmaceuticals Inc.
• Bayer AG
• Chiesi Farmaceutici SpA
• Grifols SA
• Insmed Inc
• Kamada Ltd
• Polyphor Ltd
• Recipharm AB

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bronchiectasis Therapeutic Market Size (2020-2031)
  2.1.2 Bronchiectasis Therapeutic Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Bronchiectasis Therapeutic by Country/Region (2020, 2024 & 2031)
2.2 Bronchiectasis Therapeutic Segment by Type
  2.2.1 Antibiotics
  2.2.2 Expectorants
  2.2.3 Others
2.3 Bronchiectasis Therapeutic Market Size by Type
  2.3.1 Bronchiectasis Therapeutic Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Bronchiectasis Therapeutic Market Size Market Share by Type (2020-2025)
2.4 Bronchiectasis Therapeutic Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Bronchiectasis Therapeutic Market Size by Application
  2.5.1 Bronchiectasis Therapeutic Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Bronchiectasis Therapeutic Market Size Market Share by Application (2020-2025)

3 BRONCHIECTASIS THERAPEUTIC MARKET SIZE BY PLAYER

3.1 Bronchiectasis Therapeutic Market Size Market Share by Player
  3.1.1 Global Bronchiectasis Therapeutic Revenue by Player (2020-2025)
  3.1.2 Global Bronchiectasis Therapeutic Revenue Market Share by Player (2020-2025)
3.2 Global Bronchiectasis Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BRONCHIECTASIS THERAPEUTIC BY REGION

4.1 Bronchiectasis Therapeutic Market Size by Region (2020-2025)
4.2 Global Bronchiectasis Therapeutic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bronchiectasis Therapeutic Market Size Growth (2020-2025)
4.4 APAC Bronchiectasis Therapeutic Market Size Growth (2020-2025)
4.5 Europe Bronchiectasis Therapeutic Market Size Growth (2020-2025)
4.6 Middle East & Africa Bronchiectasis Therapeutic Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Bronchiectasis Therapeutic Market Size by Country (2020-2025)
5.2 Americas Bronchiectasis Therapeutic Market Size by Type (2020-2025)
5.3 Americas Bronchiectasis Therapeutic Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Bronchiectasis Therapeutic Market Size by Region (2020-2025)
6.2 APAC Bronchiectasis Therapeutic Market Size by Type (2020-2025)
6.3 APAC Bronchiectasis Therapeutic Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Bronchiectasis Therapeutic Market Size by Country (2020-2025)
7.2 Europe Bronchiectasis Therapeutic Market Size by Type (2020-2025)
7.3 Europe Bronchiectasis Therapeutic Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bronchiectasis Therapeutic by Region (2020-2025)
8.2 Middle East & Africa Bronchiectasis Therapeutic Market Size by Type (2020-2025)
8.3 Middle East & Africa Bronchiectasis Therapeutic Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BRONCHIECTASIS THERAPEUTIC MARKET FORECAST

10.1 Global Bronchiectasis Therapeutic Forecast by Region (2026-2031)
  10.1.1 Global Bronchiectasis Therapeutic Forecast by Region (2026-2031)
  10.1.2 Americas Bronchiectasis Therapeutic Forecast
  10.1.3 APAC Bronchiectasis Therapeutic Forecast
  10.1.4 Europe Bronchiectasis Therapeutic Forecast
  10.1.5 Middle East & Africa Bronchiectasis Therapeutic Forecast
10.2 Americas Bronchiectasis Therapeutic Forecast by Country (2026-2031)
  10.2.1 United States Market Bronchiectasis Therapeutic Forecast
  10.2.2 Canada Market Bronchiectasis Therapeutic Forecast
  10.2.3 Mexico Market Bronchiectasis Therapeutic Forecast
  10.2.4 Brazil Market Bronchiectasis Therapeutic Forecast
10.3 APAC Bronchiectasis Therapeutic Forecast by Region (2026-2031)
  10.3.1 China Bronchiectasis Therapeutic Market Forecast
  10.3.2 Japan Market Bronchiectasis Therapeutic Forecast
  10.3.3 Korea Market Bronchiectasis Therapeutic Forecast
  10.3.4 Southeast Asia Market Bronchiectasis Therapeutic Forecast
  10.3.5 India Market Bronchiectasis Therapeutic Forecast
  10.3.6 Australia Market Bronchiectasis Therapeutic Forecast
10.4 Europe Bronchiectasis Therapeutic Forecast by Country (2026-2031)
  10.4.1 Germany Market Bronchiectasis Therapeutic Forecast
  10.4.2 France Market Bronchiectasis Therapeutic Forecast
  10.4.3 UK Market Bronchiectasis Therapeutic Forecast
  10.4.4 Italy Market Bronchiectasis Therapeutic Forecast
  10.4.5 Russia Market Bronchiectasis Therapeutic Forecast
10.5 Middle East & Africa Bronchiectasis Therapeutic Forecast by Region (2026-2031)
  10.5.1 Egypt Market Bronchiectasis Therapeutic Forecast
  10.5.2 South Africa Market Bronchiectasis Therapeutic Forecast
  10.5.3 Israel Market Bronchiectasis Therapeutic Forecast
  10.5.4 Turkey Market Bronchiectasis Therapeutic Forecast
10.6 Global Bronchiectasis Therapeutic Forecast by Type (2026-2031)
10.7 Global Bronchiectasis Therapeutic Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Bronchiectasis Therapeutic Forecast

11 KEY PLAYERS ANALYSIS

11.1 GlaxoSmithKline
  11.1.1 GlaxoSmithKline Company Information
  11.1.2 GlaxoSmithKline Bronchiectasis Therapeutic Product Offered
  11.1.3 GlaxoSmithKline Bronchiectasis Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 GlaxoSmithKline Main Business Overview
  11.1.5 GlaxoSmithKline Latest Developments
11.2 Alitair Pharmaceuticals Inc.
  11.2.1 Alitair Pharmaceuticals Inc. Company Information
  11.2.2 Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Product Offered
  11.2.3 Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Alitair Pharmaceuticals Inc. Main Business Overview
  11.2.5 Alitair Pharmaceuticals Inc. Latest Developments
11.3 Bayer AG
  11.3.1 Bayer AG Company Information
  11.3.2 Bayer AG Bronchiectasis Therapeutic Product Offered
  11.3.3 Bayer AG Bronchiectasis Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bayer AG Main Business Overview
  11.3.5 Bayer AG Latest Developments
11.4 Chiesi Farmaceutici SpA
  11.4.1 Chiesi Farmaceutici SpA Company Information
  11.4.2 Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Product Offered
  11.4.3 Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Chiesi Farmaceutici SpA Main Business Overview
  11.4.5 Chiesi Farmaceutici SpA Latest Developments
11.5 Grifols SA
  11.5.1 Grifols SA Company Information
  11.5.2 Grifols SA Bronchiectasis Therapeutic Product Offered
  11.5.3 Grifols SA Bronchiectasis Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Grifols SA Main Business Overview
  11.5.5 Grifols SA Latest Developments
11.6 Insmed Inc
  11.6.1 Insmed Inc Company Information
  11.6.2 Insmed Inc Bronchiectasis Therapeutic Product Offered
  11.6.3 Insmed Inc Bronchiectasis Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Insmed Inc Main Business Overview
  11.6.5 Insmed Inc Latest Developments
11.7 Kamada Ltd
  11.7.1 Kamada Ltd Company Information
  11.7.2 Kamada Ltd Bronchiectasis Therapeutic Product Offered
  11.7.3 Kamada Ltd Bronchiectasis Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Kamada Ltd Main Business Overview
  11.7.5 Kamada Ltd Latest Developments
11.8 Polyphor Ltd
  11.8.1 Polyphor Ltd Company Information
  11.8.2 Polyphor Ltd Bronchiectasis Therapeutic Product Offered
  11.8.3 Polyphor Ltd Bronchiectasis Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Polyphor Ltd Main Business Overview
  11.8.5 Polyphor Ltd Latest Developments
11.9 Recipharm AB
  11.9.1 Recipharm AB Company Information
  11.9.2 Recipharm AB Bronchiectasis Therapeutic Product Offered
  11.9.3 Recipharm AB Bronchiectasis Therapeutic Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Recipharm AB Main Business Overview
  11.9.5 Recipharm AB Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Bronchiectasis Therapeutic Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Bronchiectasis Therapeutic Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antibiotics
Table 4. Major Players of Expectorants
Table 5. Major Players of Others
Table 6. Bronchiectasis Therapeutic Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Bronchiectasis Therapeutic Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Bronchiectasis Therapeutic Market Size Market Share by Type (2020-2025)
Table 9. Bronchiectasis Therapeutic Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Bronchiectasis Therapeutic Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Bronchiectasis Therapeutic Market Size Market Share by Application (2020-2025)
Table 12. Global Bronchiectasis Therapeutic Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Bronchiectasis Therapeutic Revenue Market Share by Player (2020-2025)
Table 14. Bronchiectasis Therapeutic Key Players Head office and Products Offered
Table 15. Bronchiectasis Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Bronchiectasis Therapeutic Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Bronchiectasis Therapeutic Market Size Market Share by Region (2020-2025)
Table 20. Global Bronchiectasis Therapeutic Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Bronchiectasis Therapeutic Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Bronchiectasis Therapeutic Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Bronchiectasis Therapeutic Market Size Market Share by Country (2020-2025)
Table 24. Americas Bronchiectasis Therapeutic Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Bronchiectasis Therapeutic Market Size Market Share by Type (2020-2025)
Table 26. Americas Bronchiectasis Therapeutic Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Bronchiectasis Therapeutic Market Size Market Share by Application (2020-2025)
Table 28. APAC Bronchiectasis Therapeutic Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Bronchiectasis Therapeutic Market Size Market Share by Region (2020-2025)
Table 30. APAC Bronchiectasis Therapeutic Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Bronchiectasis Therapeutic Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Bronchiectasis Therapeutic Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Bronchiectasis Therapeutic Market Size Market Share by Country (2020-2025)
Table 34. Europe Bronchiectasis Therapeutic Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Bronchiectasis Therapeutic Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Bronchiectasis Therapeutic Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Bronchiectasis Therapeutic Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Bronchiectasis Therapeutic Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Bronchiectasis Therapeutic
Table 40. Key Market Challenges & Risks of Bronchiectasis Therapeutic
Table 41. Key Industry Trends of Bronchiectasis Therapeutic
Table 42. Global Bronchiectasis Therapeutic Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Bronchiectasis Therapeutic Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Bronchiectasis Therapeutic Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Bronchiectasis Therapeutic Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. GlaxoSmithKline Details, Company Type, Bronchiectasis Therapeutic Area Served and Its Competitors
Table 47. GlaxoSmithKline Bronchiectasis Therapeutic Product Offered
Table 48. GlaxoSmithKline Bronchiectasis Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. GlaxoSmithKline Main Business
Table 50. GlaxoSmithKline Latest Developments
Table 51. Alitair Pharmaceuticals Inc. Details, Company Type, Bronchiectasis Therapeutic Area Served and Its Competitors
Table 52. Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Product Offered
Table 53. Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Alitair Pharmaceuticals Inc. Main Business
Table 55. Alitair Pharmaceuticals Inc. Latest Developments
Table 56. Bayer AG Details, Company Type, Bronchiectasis Therapeutic Area Served and Its Competitors
Table 57. Bayer AG Bronchiectasis Therapeutic Product Offered
Table 58. Bayer AG Bronchiectasis Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Bayer AG Main Business
Table 60. Bayer AG Latest Developments
Table 61. Chiesi Farmaceutici SpA Details, Company Type, Bronchiectasis Therapeutic Area Served and Its Competitors
Table 62. Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Product Offered
Table 63. Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Chiesi Farmaceutici SpA Main Business
Table 65. Chiesi Farmaceutici SpA Latest Developments
Table 66. Grifols SA Details, Company Type, Bronchiectasis Therapeutic Area Served and Its Competitors
Table 67. Grifols SA Bronchiectasis Therapeutic Product Offered
Table 68. Grifols SA Bronchiectasis Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Grifols SA Main Business
Table 70. Grifols SA Latest Developments
Table 71. Insmed Inc Details, Company Type, Bronchiectasis Therapeutic Area Served and Its Competitors
Table 72. Insmed Inc Bronchiectasis Therapeutic Product Offered
Table 73. Insmed Inc Bronchiectasis Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Insmed Inc Main Business
Table 75. Insmed Inc Latest Developments
Table 76. Kamada Ltd Details, Company Type, Bronchiectasis Therapeutic Area Served and Its Competitors
Table 77. Kamada Ltd Bronchiectasis Therapeutic Product Offered
Table 78. Kamada Ltd Bronchiectasis Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Kamada Ltd Main Business
Table 80. Kamada Ltd Latest Developments
Table 81. Polyphor Ltd Details, Company Type, Bronchiectasis Therapeutic Area Served and Its Competitors
Table 82. Polyphor Ltd Bronchiectasis Therapeutic Product Offered
Table 83. Polyphor Ltd Bronchiectasis Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Polyphor Ltd Main Business
Table 85. Polyphor Ltd Latest Developments
Table 86. Recipharm AB Details, Company Type, Bronchiectasis Therapeutic Area Served and Its Competitors
Table 87. Recipharm AB Bronchiectasis Therapeutic Product Offered
Table 88. Recipharm AB Bronchiectasis Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Recipharm AB Main Business
Table 90. Recipharm AB Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Bronchiectasis Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bronchiectasis Therapeutic Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Bronchiectasis Therapeutic Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Bronchiectasis Therapeutic Sales Market Share by Country/Region (2024)
Figure 8. Bronchiectasis Therapeutic Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Bronchiectasis Therapeutic Market Size Market Share by Type in 2024
Figure 10. Bronchiectasis Therapeutic in Hospital Pharmacies
Figure 11. Global Bronchiectasis Therapeutic Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Bronchiectasis Therapeutic in Retail Pharmacies
Figure 13. Global Bronchiectasis Therapeutic Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 14. Bronchiectasis Therapeutic in Online Pharmacies
Figure 15. Global Bronchiectasis Therapeutic Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Bronchiectasis Therapeutic Market Size Market Share by Application in 2024
Figure 17. Global Bronchiectasis Therapeutic Revenue Market Share by Player in 2024
Figure 18. Global Bronchiectasis Therapeutic Market Size Market Share by Region (2020-2025)
Figure 19. Americas Bronchiectasis Therapeutic Market Size 2020-2025 ($ millions)
Figure 20. APAC Bronchiectasis Therapeutic Market Size 2020-2025 ($ millions)
Figure 21. Europe Bronchiectasis Therapeutic Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Bronchiectasis Therapeutic Market Size 2020-2025 ($ millions)
Figure 23. Americas Bronchiectasis Therapeutic Value Market Share by Country in 2024
Figure 24. United States Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Bronchiectasis Therapeutic Market Size Market Share by Region in 2024
Figure 29. APAC Bronchiectasis Therapeutic Market Size Market Share by Type (2020-2025)
Figure 30. APAC Bronchiectasis Therapeutic Market Size Market Share by Application (2020-2025)
Figure 31. China Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 35. India Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Bronchiectasis Therapeutic Market Size Market Share by Country in 2024
Figure 38. Europe Bronchiectasis Therapeutic Market Size Market Share by Type (2020-2025)
Figure 39. Europe Bronchiectasis Therapeutic Market Size Market Share by Application (2020-2025)
Figure 40. Germany Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 41. France Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Bronchiectasis Therapeutic Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Bronchiectasis Therapeutic Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Bronchiectasis Therapeutic Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Bronchiectasis Therapeutic Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 54. APAC Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 55. Europe Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 57. United States Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 58. Canada Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 59. Mexico Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 60. Brazil Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 61. China Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 62. Japan Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 63. Korea Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 65. India Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 66. Australia Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 67. Germany Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 68. France Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 69. UK Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 70. Italy Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 71. Russia Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 72. Egypt Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 73. South Africa Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 74. Israel Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 75. Turkey Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)
Figure 76. Global Bronchiectasis Therapeutic Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Bronchiectasis Therapeutic Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Bronchiectasis Therapeutic Market Size 2026-2031 ($ millions)